Publication Name	World Journal of Clinical Cases
Manuscript ID	91158
Country	China

Category	Oncology
Manuscript Type	Case Report
Article Title	Thymic carcinoid with multiple bone metastases: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Chun-Qiao Chen, Ming-Yue Huang, Min Pan, Qiu-Qiu Chen, Fei-Fei Wei and Hui Huang
Funding Agency and Grant Number	Funding Agency Grant Number Guangxi Guilin Science and Technology Fund 20190218-7-6
Corresponding Author	Hui Huang, MD, Doctor, Department of Oncology, People’s Hospital of Guilin, No. 12 Wenming Road, Guilin 541000, Guangxi Zhuang Autonomous Region, China. huanghui25002@163.com
Key Words	Thymic carcinoid; Anlotinib; Multitargeted tyrosine kinase inhibitor; Bone metastasis; Case report
Core Tip	Here, we report a 77-year-old man diagnosed with thymic carcinoid (TC) with multiple bone metastases, and the study reports the rapid contraction of thymoid carcinoma after therapy with the multitargeted tyrosine kinase inhibitor anlotinib. The treatment has shown good efficacy, with a long stable disease benefit of more than 2.5 years (until March 2022). These findings demonstrated that anlotinib is a promising treatment regimen for TC tumors with multiple bone metastases.
Citation	Chen CQ, Huang MY, Pan M, Chen QQ, Wei FF, Huang H. Thymic carcinoid with multiple bone metastases: A case report. World J Clin Cases 2024; 12(13): 2275-2280

Received	2023-12-23 08:27
Peer-Review Started	2023-12-23 08:27
To Make the First Decision
Return for Revision	2024-01-30 22:00
Revised	2024-02-09 08:28
Second Decision	2024-03-28 06:50
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-03-28 08:01
Articles in Press	2024-03-28 08:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-17 06:34

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com